A trade group representing compounding pharmacies has filed a lawsuit against the Food and Drug Administration (FDA) for ...

(Reuters) -Eli Lilly said on Tuesday it cut the price for vials of its weight-loss drug Zepbound by $50 or more and expanded ...

Patients report that GLP-1 drugs like Ozempic and Mounjaro reduce “food noise,” the constant mental chatter about eating.

Shares of Hims & Hers Health tumbled 18% premarket on Tuesday as Wall Street analysts questioned the telehealth provider's ...

Investors are scrambling to adjust, after the telehealth specialist Hims & Hers said it would stop selling an alternative to ...

Hims & Hers shares fell on Tuesday, a day after the company released fourth-quarter results that disappointed on gross margin ...

Coverage complications are not unusual in the U.S. health care system. But the challenge is magnified for these obesity ...

Despite carbohydrates being an essential macronutrient, when it comes to weight loss, carbs like pasta, rice, corn, bread and ...

After the FDA removed semaglutide injection products from a shortage list, compounders like Hims have 60-90 days to stop ...

The telehealth company Hims & Hers has made waves for its Super Bowl ad that plugged its lower-priced form of injectable ...

New research reveals men and women process breakfast nutrients differently, reshaping weight loss strategies with a focus on ...